For: | Wu ZC, Xiong L, Wang LX, Miao XY, Liu ZR, Li DQ, Zou Q, Liu KJ, Zhao H, Yang ZL. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol 2017; 23(14): 2601-2612 [PMID: 28465645 DOI: 10.3748/wjg.v23.i14.2601] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i14/2601.htm |
Number | Citing Articles |
1 |
Tian-Run Lv, Fei Liu, Zuo-Yu Liang, Rui-Qi Zou, Wen-Jie Ma, Hai-Jie Hu, Fu-Yu Li. Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1116275
|
2 |
Wei Huang, Tian-Run Lv, Lang Bai, Hong Tang. The significance of neuroendocrine component in cases with intrahepatic cholangiocarcinoma: A SEER-based retrospective cohort study. Current Problems in Surgery 2024; 61(11): 101608 doi: 10.1016/j.cpsurg.2024.101608
|
3 |
Hong-Shuai Li, Tao He, Li-Li Yang. Adenosquamous carcinoma of the digestive system: a literature review. Scandinavian Journal of Gastroenterology 2020; 55(11): 1268 doi: 10.1080/00365521.2020.1832571
|
4 |
Ramy R. Saleh, Jesús Fuentes Antrás, Paloma Peinado, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis. Cancer Treatment Reviews 2019; 77: 11 doi: 10.1016/j.ctrv.2019.05.006
|
5 |
Muhong Guo, Ge Ma, Xiaolan Zhang, Weiwei Tang, Junfeng Shi, Qian Wang, Ye Cheng, Bin Zhang, Jin Xu. ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling. Aging 2020; 12(13): 13115 doi: 10.18632/aging.103400
|
6 |
Gilbert Murimwa, Caitlin Hester, John C. Mansour, Patricio M. Polanco, Matthew R. Porembka, Sam C. Wang, Herbert J. Zeh, Adam C. Yopp. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database. Journal of Gastrointestinal Surgery 2021; 25(7): 1815 doi: 10.1007/s11605-020-04729-w
|
7 |
Hao Jin, Min Cui. Recognition of potential therapeutic role of 2‐hydroxy‐3‐methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis. Fundamental & Clinical Pharmacology 2022; 36(2): 350 doi: 10.1111/fcp.12740
|
8 |
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata, Yasuharu Imai. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis. Clinical Journal of Gastroenterology 2020; 13(6): 1273 doi: 10.1007/s12328-020-01204-6
|
9 |
Zhengchun Wu, Xiongying Miao, Yuanfang Zhang, Daiqiang Li, Qiong Zou, Yuan Yuan, Rushi Liu, Zhulin Yang. XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00070
|
10 |
Maura Lima Pereira Bueno, Sara Teresinha Olalla Saad, Fernanda Marconi Roversi. WNT5A in tumor development and progression: A comprehensive review. Biomedicine & Pharmacotherapy 2022; 155: 113599 doi: 10.1016/j.biopha.2022.113599
|